Sign Up Today and Learn More About BioTheryX Stock
Invest in or calculate the value of your shares in BioTheryX or other pre-IPO companies through EquityZen's platform.
BioTheryX Stock (BIOX)
BioTheryX is a clinical-stage biopharmaceutical company that focuses on the development of therapies for hematological malignancies.
About BioTheryX Stock
Founded
2007
Headquarters
Chappaqua, NY, US
Industries
Science and Engineering, Health Care, Biotechnology
BioTheryX focuses on the development of therapies for hematological malignancies. It intends to leverage its extensive experience and proven commercial success to deliver efficacious therapies to patients with unmet medical needs more quickly and less expensively than the biomedical industry traditionally can and does. To do so, they are exploiting enhanced biology-driven models to identify effective core molecules that can be rapidly exploited using focused and prioritized chemistry approaches coupled with clinically proven translational approaches targeted for cancer and immune dysfunction. The company was founded in 2007 and is headquartered in Chappaqua, New York.
BioTheryX Press Mentions
Stay in the know about the latest news on BioTheryX
Sos1 protein degraders, pharmaceutical compositions, and therapeutic …
patents • Apr 03, 2025
Pde4 degraders, pharmaceutical compositions, and therapeutic applications
patents • Apr 03, 2025
Kras protein degraders, pharmaceutical compositions thereof, and their …
patents • Apr 03, 2025
Cdk protein degraders, pharmaceutical compositions, and therapeutic …
patents • Apr 03, 2025
Biotheryx Announces U.S. FDA Clearance of Investigational New Drug Application for BTX-9341, a First-In-Class, Dual ...
prnewswire • May 19, 2024
BioTheryX Management
Leadership team at BioTheryX
Chief Business Officer
Sahm Nasseri
Chief Financial Officer
Jeff Caravella
Join now and verify your accreditation status to gain access to:
- BioTheryX Current Valuation
- BioTheryX Stock Price
- BioTheryX Management
- Available deals in BioTheryX and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- BioTheryX Cap Table and Funding History by Share Class and Liquidity Preferences
- BioTheryX Revenue and Financials
- BioTheryX Highlights
- BioTheryX Business Model
- BioTheryX Risk Factors
- BioTheryX Research Report from SACRA Research
Trading BioTheryX Stock
How to invest in BioTheryX stock?
Accredited investors can buy pre-IPO stock in companies like BioTheryX through EquityZen funds. These investments are made available by existing BioTheryX shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell BioTheryX stock?
Shareholders can sell their BioTheryX stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
